Thomas Kuilman

9.4k citations

25 papers · 6.7k indexed · 4 hit papers · h-index 16

Impact in

Aging top 0.5%
Physiology top 0.5%
- Telomeres, Telomerase, and Senescence

Papers in

Oncology 16
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 5
- Cancer Cells and Metastasis 3
- Lung Cancer Research Studies 2
Immunology 8

Co-authors: Daniel S. Peeper Wolter J. Mooi Chrysiis Michaloglou Liesbeth C.W. Vredeveld Christophe Desmet Lucien A. Aarden Remco van Doorn Sirith Douma
Journals: Cell Reports (2 papers)Nature (2 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)Nature reviews. Cancer (1 paper)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Thomas Kuilman

24 papers receiving 6.7k citations

Hit Papers

align trajectories log scale

The essence of senescence: Figure 1. 2010 · 1.6k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Genes & Development
2009 Nature reviews. Cancer
2008 Cell
2005 Nature

Peers

Countries citing papers authored by Thomas Kuilman

Since Specialization

Citations

This map shows the geographic impact of Thomas Kuilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kuilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kuilman more than expected).

Fields of papers citing papers by Thomas Kuilman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kuilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kuilman. The network helps show where Thomas Kuilman may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Kuilman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Kuilman Line = papers co-authored together Thomas Kuilman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Non-clinical evaluation of NT-175, an autologous T cell product engineered to express an HLA-A02:01-restricted TCR targeting TP53 R175H and resistant to TGF-b inhibition. Journal of Clinical Oncology* ·Jun Yuan Wang, Jennifer Ma, Beppe Moiso, 정서현, Christy Rose Peter, Xiangjun Kong, Paula Kroon, Serigne Bamba Gaye, Aohua Wu, Laura Bies, Julia K. L. Walker, Robbert M. Spaapen, 史ヱ伊東, Oscar Krijgsman, Itzel Leonardo-Cruz, Yoon-Jung Shin, Thomas Kuilman, Jeroen van Heijst, Gavin Bendle, Arianne Perez	2024	0
2	Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition. Journal of Clinical Oncology* ·Jennifer Ma, Jun Yuan Wang, Christy Rose Peter, V Timofeenko, Xiangjun Kong, Paula Kroon, Serigne Bamba Gaye, 史ヱ伊東, Kuruba Lakshman, Paula Ernestina Leal de Oliveira Cardoso, Jules Gadiot, Beppe Moiso, 정서현, Ton N. Schumacher, Mohadeseh Mohammad Salehi, Thomas Kuilman, Jeroen van Heijst, Gavin Bendle, Arianne Perez	2024	2
3	The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma Molecular Cancer Research ·D. V. Shtansky, Joleen J.H. Traets, door W.R, Andrea P. Torres‐Flores, Ji‐Ying Song, Scott I Berman, Thomas Kuilman, Daniel S. Peeper	2023	4
4	RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells Cell Reports Medicine ·Zhengkui Zhang, Xiangjun Kong, Maarten A. Ligtenberg, Eugeniy Butkov, Nils L. Visser, Beaunelle de Bruijn, Kelly E. Stecker, O Horn, Thomas Kuilman, Esmée P. Hoefsmit, David W. Vredevoogd, Georgi Apriamashvili, Monica Chande, Emile E. Voest, Sjoerd Klarenbeek, Maarten Altelaar, Daniel S. Peeper	2022	30
5	Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4 Clinical Cancer Research ·Oscar Krijgsman, Kristel Kemper, Julia Boshuizen, David W. Vredevoogd, Elisa A. Rozeman, 白沢郁郎, Beaunelle de Bruijn, Paulien Cornelissen‐Steijger, Aida Shahrabi, Martin Del Castillo Velasco‐Herrera, Ji‐Ying Song, Maarten A. Ligtenberg, Wei Wang, Thomas Kuilman, Petra Ross‐Macdonald, John B.A.G. Haanen, David J. Adams, Christian U. Blank, Daniel S. Peeper	2021	3
6	Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma Journal of Translational Medicine ·Willemijn S.M.E. Theelen, Oscar Krijgsman, Kim Monkhorst, Thomas Kuilman, Dennis Peters, Sten Cornelissen, Maarten A. Ligtenberg, Stefan M. Willems, J. L. G. Blaauwgeers, Carel J.M. van Noesel, Daniel S. Peeper, Michel M. van den Heuvel, Katja Schulze	2020	9
7	Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer PLoS ONE ·Willemijn S.M.E. Theelen, Thomas Kuilman, Katja Schulze, Wei Zou, Oscar Krijgsman, Dennis Peters, Sten Cornelissen, Kim Monkhorst, Everettz Zimmerman, Teiko Sumiyoshi, Lukas C. Amler, Stefan M. Willems, J. L. G. Blaauwgeers, Carel J.M. van Noesel, Daniel S. Peeper, Michel M. van den Heuvel, Marcin Kowanetz	2019	9
8	XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data BMC Bioinformatics ·Roelof J.C. Kluin, Kristel Kemper, Thomas Kuilman, Julian R. de Ruiter, Vivek Iyer, Josep V. Forment, Paulien Cornelissen‐Steijger, Iris de Rink, Petra ter Brugge, Ji‐Ying Song, Sjoerd Klarenbeek, Ultan McDermott, Jos Jonkers, Arno Velds, David J. Adams, Daniel S. Peeper, Oscar Krijgsman	2018	72
9	Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors Nature Medicine ·Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman, Aida Shahrabi, Giannis Dallas, Maarten A. Ligtenberg, David W. Vredevoogd, Kristel Kemper, Thomas Kuilman, Ji‐Ying Song, Nora Pencheva, Jens Mortensen, Marnix Geukes Foppen, Elisa A. Rozeman, Christian U. Blank, Maarten L. Janmaat, David Satijn, Esther C.W. Breij, Daniel S. Peeper, Paul W.H.I. Parren	2018	164
10	Cancer drug addiction is relayed by an ERK2-dependent phenotype switch Nature ·Xiangjun Kong, Thomas Kuilman, Aida Shahrabi, Julia Boshuizen, Kristel Kemper, Ji-Ying Song, Hans W.M. Niessen, Elisa A. Rozeman, Marnix H. Geukes Foppen, Christian U. Blank, Daniel S. Peeper	2017	110
11	Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients Cell Reports ·Ekaterina A. Semenova, Min‐Chul Kwon, Kim Monkhorst, Ji‐Ying Song, Rajith Bhaskaran, Oscar Krijgsman, Thomas Kuilman, Dennis Peters, Wieneke A. Buikhuisen, Egbert F. Smit, Colin E.J. Pritchard, Miranda Cozijnsen, Jan van der Vliet, John Zevenhoven, Jan-Paul Lambooij, Natalie Proost, Erwin van Montfort, Arno Velds, Ivo J. Huijbers, Anton Berns	2016	106
12	BRAFV600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts Cell Reports ·Kristel Kemper, Oscar Krijgsman, Xiangjun Kong, Paulien Cornelissen‐Steijger, Aida Shahrabi, Fleur Weeber, Daphne van der Velden, Onno B. Bleijerveld, Thomas Kuilman, Roelof J.C. Kluin, Chong Sun, Emile E. Voest, Young Seok Ju, Ton N. Schumacher, Maarten Altelaar, Ultan McDermott, David J. Adams, Christian U. Blank, John B.A.G. Haanen, Daniel S. Peeper	2016	41
13	Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts EMBO Molecular Medicine ·Kristel Kemper, Oscar Krijgsman, Paulien Cornelissen‐Steijger, Aida Shahrabi, Fleur Weeber, Ji‐Ying Song, Thomas Kuilman, Daniël J. Vis, Lodewyk F.A. Wessels, Emile E. Voest, Ton N. Schumacher, Christian U. Blank, David J. Adams, John B.A.G. Haanen, Daniel S. Peeper	2015	103
14	Nur1 Dephosphorylation Confers Positive Feedback to Mitotic Exit Phosphatase Activation in Budding Yeast PLoS Genetics ·Anahita Moharamian, Thomas Kuilman, Frank Uhlmann	2015	4
15	Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases Proceedings of the National Academy of Sciences ·Fleur Weeber, Marc van de Wetering, Marlous Hoogstraat, Krijn K. Dijkstra, Oscar Krijgsman, Thomas Kuilman, Christa G.M. Gadellaa-van Hooijdonk, Daphne van der Velden, Daniel S. Peeper, Edwin Cuppen, Robert G. Vries, Hans Clevers, Emile E. Voest	2015	349
16	Identification of C dk targets that control cytokinesis The EMBO Journal ·Thomas Kuilman, Alessio Maiolica, Anahita Moharamian, Pronoy Kumar Paul, Ruedi Aebersold, Frank Uhlmann	2014	47
17	The essence of senescence: Figure 1. Genes & Development ·Thomas Kuilman, Chrysiis Michaloglou, Wolter J. Mooi, Daniel S. Peeper Hit paper breakdown →	2010	1626
18	Senescence-messaging secretome: SMS-ing cellular stress Nature reviews. Cancer ·Thomas Kuilman, Daniel S. Peeper Hit paper breakdown →	2009	700
19	Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network Cell ·Thomas Kuilman, Chrysiis Michaloglou, Liesbeth C.W. Vredeveld, Sirith Douma, Remco van Doorn, Christophe Desmet, Lucien A. Aarden, Wolter J. Mooi, Daniel S. Peeper Hit paper breakdown →	2008	1587
20	BRAFE600-associated senescence-like cell cycle arrest of human naevi Nature ·Chrysiis Michaloglou, Liesbeth C.W. Vredeveld, Marı́a S. Soengas, Christophe Denoyelle, Thomas Kuilman, Chantal M.A.M. van der Horst, Donné Majoor, Jerry W. Shay, Wolter J. Mooi, Daniel S. Peeper Hit paper breakdown →	2005	1604

About Thomas Kuilman

Thomas Kuilman is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Cell Biology, having authored 25 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Melanoma and MAPK Pathways (6 papers), CAR-T cell therapy research (5 papers), Telomeres, Telomerase, and Senescence (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Aging (342 citations), Physiology (2.7k citations), Cancer Research (1.2k citations), Oncology (1.9k citations) and Immunology (1.4k citations). Thomas Kuilman has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Daniel S. Peeper, Wolter J. Mooi, Chrysiis Michaloglou, Liesbeth C.W. Vredeveld, Christophe Desmet, Lucien A. Aarden, Remco van Doorn, Sirith Douma, Jerry W. Shay and Chantal M.A.M. van der Horst. Their work appears in journals such as Cell Reports, Nature, Journal of Clinical Oncology, Clinical Cancer Research and Nature reviews. Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact